GB0327195D0 - Novel use - Google Patents

Novel use

Info

Publication number
GB0327195D0
GB0327195D0 GBGB0327195.4A GB0327195A GB0327195D0 GB 0327195 D0 GB0327195 D0 GB 0327195D0 GB 0327195 A GB0327195 A GB 0327195A GB 0327195 D0 GB0327195 D0 GB 0327195D0
Authority
GB
United Kingdom
Prior art keywords
novel use
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0327195.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to GBGB0327195.4A priority Critical patent/GB0327195D0/en
Publication of GB0327195D0 publication Critical patent/GB0327195D0/en
Priority to JP2006540363A priority patent/JP2007511577A/ja
Priority to US10/595,885 priority patent/US20070142378A1/en
Priority to PCT/EP2004/013248 priority patent/WO2005053700A1/en
Priority to EP04803222A priority patent/EP1684765A1/en
Priority to TW093135507A priority patent/TW200529858A/zh
Priority to ARP040104268A priority patent/AR046641A1/es
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GBGB0327195.4A 2003-11-21 2003-11-21 Novel use Ceased GB0327195D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0327195.4A GB0327195D0 (en) 2003-11-21 2003-11-21 Novel use
JP2006540363A JP2007511577A (ja) 2003-11-21 2004-11-19 （２ｓ，３ｓ）−２−（３−クロロフェニル）−３，５，５−トリメチル−２−モルホリノールの使用
US10/595,885 US20070142378A1 (en) 2003-11-21 2004-11-19 Method of treating restless legs syndrome and/or periodic limb movement disorder with (2s,3s) 2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol
PCT/EP2004/013248 WO2005053700A1 (en) 2003-11-21 2004-11-19 Use of (2s,3s)2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol
EP04803222A EP1684765A1 (en) 2003-11-21 2004-11-19 Use of (2s, 3s) 2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol
TW093135507A TW200529858A (en) 2003-11-21 2004-11-19 Novel use
ARP040104268A AR046641A1 (es) 2003-11-21 2004-11-19 Uso del (+)-(2s, 3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0327195.4A GB0327195D0 (en) 2003-11-21 2003-11-21 Novel use

Publications (1)

Publication Number Publication Date
GB0327195D0 true GB0327195D0 (en) 2003-12-24

Family

ID=29764268

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0327195.4A Ceased GB0327195D0 (en) 2003-11-21 2003-11-21 Novel use

Country Status (7)

Country Link
US (1) US20070142378A1 (https=)
EP (1) EP1684765A1 (https=)
JP (1) JP2007511577A (https=)
AR (1) AR046641A1 (https=)
GB (1) GB0327195D0 (https=)
TW (1) TW200529858A (https=)
WO (1) WO2005053700A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425445D0 (en) * 2004-11-18 2004-12-22 Smithkline Beecham Corp Novel compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL193622B1 (pl) * 1998-01-21 2007-02-28 Glaxo Group Ltd Farmaceutycznie czynny morfolinol, zawierająca gokompozycja oraz jego zastosowanie
US7098206B2 (en) * 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6342496B1 (en) * 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
EP1336406A1 (en) * 2002-02-14 2003-08-20 Solvay Pharmaceuticals B.V. Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitory activity

Also Published As

Publication number Publication date
JP2007511577A (ja) 2007-05-10
US20070142378A1 (en) 2007-06-21
AR046641A1 (es) 2005-12-14
WO2005053700A1 (en) 2005-06-16
EP1684765A1 (en) 2006-08-02
TW200529858A (en) 2005-09-16

Similar Documents

Publication Publication Date Title
DE502004011703D1 (en) N-heterocyclyl-phenylsubstituierte cyclische ketoenole
DE602004012071D1 (en) T-hilfe
DE602004020356D1 (en) Phenoxyessigsäurederivate
DE502004009243D1 (en) Spirocyclische cyclohexan-derivate
DE502004003476D1 (en) Standfuss
DE602004027010D1 (en) Thermotherapiehülle
DE502004006683D1 (en) Injection-locked-oscillator-schaltkreis
DE502004011852D1 (en) Nspritzventil
GB0315259D0 (en) Use
DE502004004146D1 (en) Pyrazolverbindungen
DE112004002769D2 (en) Schienengeführtes transportsystem
GB0611515D0 (en) Novel oxy-nitriles
DE602004012262D1 (en) Benzimidazolonverbindung
DE502004011343D1 (en) Rotorspinnmaschine
DE602004020525D1 (en) Imidazolderivate
GB0318094D0 (en) Novel combination
DE502004012153D1 (en) Rotorspinnmaschine
GB0302741D0 (en) Use
GB0325291D0 (en) Novel combination
DE10394343D2 (en) Berührungslose biometrische erkennung
GB0313913D0 (en) New use
IL175678A0 (en) Novel piperidine-substituted indoles-or heteroderivatives thereof
DE602004009041D1 (en) Hydroxytetrahydronaphthalenylharnstoffderivate
DE602004008281D1 (en) Avermectin-b1-monosaccharidderivative
AU155419S (en) Trivette

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)